abstract |
The present invention provides a compound having excellent histone acetyltransferase inhibitory activity against EP300 and/or CREBBP, or a pharmacologically acceptable salt thereof. The compound is represented by the following formula (1) or a pharmacologically acceptable salt thereof:n nwherein ring Q 1 , ring Q 2 , R 1 , R 2 , R 3 and R 4 respectively have the same meanings as defined in the specification. |